Arline H. Laughter
About
In The Last Decade
Arline H. Laughter
28 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 97
- Immunology 477
- Molecular Biology 453
- Pathology and Forensic Medicine 160
- Radiology, Nuclear Medicine and Imaging 131
- Oncology 124
Countries citing papers authored by Arline H. Laughter
This map shows the geographic impact of Arline H. Laughter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arline H. Laughter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arline H. Laughter more than expected).
Fields of papers citing papers by Arline H. Laughter
This network shows the impact of papers produced by Arline H. Laughter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arline H. Laughter. The network helps show where Arline H. Laughter may publish in the future.
Co-authorship network of co-authors of Arline H. Laughter
This figure shows the co-authorship network connecting the top 25 collaborators of Arline H. Laughter. A scholar is included among the top collaborators of Arline H. Laughter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arline H. Laughter. Arline H. Laughter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | HIV-1-stimulated expression of CD11/CD18 integrins and ICAM-1: a possible mechanism for extravascular dissemination of HIV-1-infected cells. | 27 |
| 3 | 29 | |
| 4 | A comparison of the regulatory effects of human monocytes, pulmonary alveolar macrophages (PAMs) and spleen macrophages upon lymphocyte responses. | 28 |
| 5 | 8 | |
| 6 | 4 | |
| 7 | 45 | |
| 8 | 105 | |
| 9 | 24 | |
| 10 | 55 | |
| 11 | Lymphoproliferative responses to antigens mediated by human pulmonary alveolar macrophages. | 73 |
| 12 | 77 | |
| 13 | 18 | |
| 14 | 18 | |
| 15 | 184 | |
| 16 | AN IMMUNODEPLETING AND IMMUNOSUPPRESSIVE DISORDER | 3 |
| 17 | 1 | |
| 18 | 4 | |
| 19 | 63 | |
| 20 | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.